Verma G - Search Results

1

Targeting oncogenic kinases: Insights on FDA approved tyrosine kinase inhibitors.

Hussain S, Mursal M, Verma G, Hasan SM, Khan MF. Hussain S, et al. Among authors: verma g. Eur J Pharmacol. 2024 May 5;970:176484. doi: 10.1016/j.ejphar.2024.176484. Epub 2024 Mar 11. Eur J Pharmacol. 2024. PMID: 38467235 Review.

2

Dibenzepinones, dibenzoxepines and benzosuberones based p38α MAP kinase inhibitors: Their pharmacophore modelling, 3D-QSAR and docking studies.

Khan MF, Verma G, Alam P, Akhter M, Bakht MA, Hasan SM, Shaquiquzzaman M, Alam MM. Khan MF, et al. Among authors: verma g. Comput Biol Med. 2019 Jul;110:175-185. doi: 10.1016/j.compbiomed.2019.05.023. Epub 2019 May 31. Comput Biol Med. 2019. PMID: 31173941

3

The therapeutic journey of pyridazinone.

Akhtar W, Shaquiquzzaman M, Akhter M, Verma G, Khan MF, Alam MM. Akhtar W, et al. Among authors: verma g. Eur J Med Chem. 2016 Nov 10;123:256-281. doi: 10.1016/j.ejmech.2016.07.061. Epub 2016 Jul 27. Eur J Med Chem. 2016. PMID: 27484513 Review.

4

Piperazine scaffold: A remarkable tool in generation of diverse pharmacological agents.

Shaquiquzzaman M, Verma G, Marella A, Akhter M, Akhtar W, Khan MF, Tasneem S, Alam MM. Shaquiquzzaman M, et al. Among authors: verma g. Eur J Med Chem. 2015 Sep 18;102:487-529. doi: 10.1016/j.ejmech.2015.07.026. Epub 2015 Jul 18. Eur J Med Chem. 2015. PMID: 26310894 Review.

5

The therapeutic voyage of pyrazole and its analogs: A review.

Khan MF, Alam MM, Verma G, Akhtar W, Akhter M, Shaquiquzzaman M. Khan MF, et al. Among authors: verma g. Eur J Med Chem. 2016 Sep 14;120:170-201. doi: 10.1016/j.ejmech.2016.04.077. Epub 2016 May 10. Eur J Med Chem. 2016. PMID: 27191614 Review.

6

Therapeutic evolution of benzimidazole derivatives in the last quinquennial period.

Akhtar W, Khan MF, Verma G, Shaquiquzzaman M, Rizvi MA, Mehdi SH, Akhter M, Alam MM. Akhtar W, et al. Among authors: verma g. Eur J Med Chem. 2017 Jan 27;126:705-753. doi: 10.1016/j.ejmech.2016.12.010. Epub 2016 Dec 5. Eur J Med Chem. 2017. PMID: 27951484 Review.

7

Molecular interactions of dioxins and DLCs with the xenosensors (PXR and CAR): An in silico risk assessment approach.

Verma G, Khan MF, Shaquiquzzaman M, Akhtar W, Akhter M, Hasan SM, Alam MM. Verma G, et al. J Mol Recognit. 2017 Dec;30(12). doi: 10.1002/jmr.2651. Epub 2017 Jun 22. J Mol Recognit. 2017. PMID: 28639323

8

Synthesis of pyrazole acrylic acid based oxadiazole and amide derivatives as antimalarial and anticancer agents.

Verma G, Chashoo G, Ali A, Khan MF, Akhtar W, Ali I, Akhtar M, Alam MM, Shaquiquzzaman M. Verma G, et al. Bioorg Chem. 2018 Apr;77:106-124. doi: 10.1016/j.bioorg.2018.01.007. Epub 2018 Jan 11. Bioorg Chem. 2018. PMID: 29353728

9

Molecular interactions of bisphenols and analogs with glucocorticoid biosynthetic pathway enzymes: an in silico approach.

Verma G, Khan MF, Akhtar W, Alam MM, Akhter M, Shaquiquzzaman M. Verma G, et al. Toxicol Mech Methods. 2018 Jan;28(1):45-54. doi: 10.1080/15376516.2017.1356415. Epub 2017 Aug 3. Toxicol Mech Methods. 2018. PMID: 28715929

10

Targeting malaria and leishmaniasis: Synthesis and pharmacological evaluation of novel pyrazole-1,3,4-oxadiazole hybrids. Part II.

Verma G, Khan MF, Mohan Nainwal L, Ishaq M, Akhter M, Bakht A, Anwer T, Afrin F, Islamuddin M, Husain I, Alam MM, Shaquiquzzaman M. Verma G, et al. Bioorg Chem. 2019 Aug;89:102986. doi: 10.1016/j.bioorg.2019.102986. Epub 2019 May 17. Bioorg Chem. 2019. PMID: 31146198

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

508 results

Search Page